Related Experiment Video
Updated: Nov 14, 2025
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Cell Models for Birth Defects Caused by Chloroethyl Nitrosourea-Induced DNA Lesions
Jiankun Cao1, Zongjian Liu2, Congxiao Wang2
1Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Abstract:
Birth defects have been linked to administration of alkylating agents during pregnancy. The anti-tumor efficacy of alkylating agents correlate with their ability to induce DNA lesions, especially interstrand crosslinks (ICLs). Yet the role of DNA damages in birth defects remains to be clarified, owing, in part, to a lack of cell models. Here we generate DNA lesions in NIH/3T3 cells to mimic defects in fetus triggered by 3-Bis(2-chloroethyl)-1-nitrosourea (BCNU, carmustine). CCK-8 assay suggests that BCNU-induced cell death was dose-dependent. Alkaline comet tests and γ-H2AX staining confirm DNA ICLs and other forms of DNA damages caused by BCNUs. The cell cycle analysis shows cells arrest in G2/M phase until crosslinks repair is complete. Taken together, all these experiments demonstrate we have successfully established normal cell models for birth defects caused by BCNU-mediated DNA damages. The model can not only guide the development of effective and low-toxicity anticancer drugs, but also be of great significance for the study of neonatal malformation triggered by BCNUs.
Insights
Researchers created cell models to study birth defects caused by the chemotherapy drug BCNU (carmustine). These models help understand DNA damage and develop safer cancer treatments and therapies for neonatal malformations.
Area of Science:
- Toxicology
- Developmental Biology
- Genetics
Background:
- Alkylating agents, used in cancer therapy, can cause birth defects.
- The exact mechanisms linking DNA damage from these agents to birth defects are not fully understood.
- A lack of suitable cell models hinders research into these developmental issues.
Purpose of the Study:
- To establish a cell model system to investigate DNA damage induced by BCNU (carmustine) relevant to birth defects.
- To characterize the DNA damage response and cell cycle effects following BCNU exposure in a cellular context.
Main Methods:
- NIH/3T3 cells were treated with varying doses of BCNU (carmustine).
- Cell viability was assessed using CCK-8 assays.
- DNA interstrand crosslinks (ICLs) and other DNA damages were confirmed via alkaline comet assays and γ-H2AX staining.
- Cell cycle progression was analyzed using flow cytometry.
Main Results:
- BCNU-induced cell death was dose-dependent.
- Alkaline comet tests and γ-H2AX staining confirmed the induction of DNA ICLs and other DNA damages.
- Cells exhibited G2/M phase arrest, which persisted until DNA crosslink repair was completed.
Conclusions:
- Successfully established NIH/3T3 cell models that mimic BCNU-induced DNA damage relevant to fetal development.
- These models are valuable for studying the etiology of BCNU-related birth defects and neonatal malformations.
- The models can aid in developing safer anticancer drugs and understanding developmental toxicity.
More Related Videos
08:13Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers
Published on: January 28, 2020
06:40Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage
Published on: October 21, 2015